COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,137 Articles (22,693 medRxiv, 8,444 bioRxiv)

Most recent first Previous |  Page 1971: Articles 19701-19710  | Next

Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., Roddick, A., Spata, E., Staplin, N., Emberson, J. R., Pessoa-Amorim, G., Peto, L., Campbell, M., Brightling, C., Prudon, B., Chadwick, D., Ustianowski, A., Ashish, A., Todd, S., Yates, B., Buttery, R., Scott, S., Maseda, D., Baillie, J. K., Buch, M. H., Chappell, L. C., Day, J. N., Faust, S. N., Jaki, T., Jeffery, K., Juszczak, E., Lim, W. S., Montgomery, A., Mumford, A., Rowan, K., Thwaites, G., Mafham, M., Haynes, R., Landray, M. J.
10.1101/2020.12.10.20245944 — Posted: 2020-12-14
Impact of mass testing during an epidemic rebound of SARS-CoV-2: A modelling study
Bosetti, P., Tran Kiem, C., Yazdanpanah, Y., Fontanet, A., Lina, B., Colizza, V., Cauchemez, S.
10.1101/2020.12.08.20246009 — Posted: 2020-12-13
Identification of four linear B-cell epitopes on the SARS-CoV-2 spike protein able to elicit neutralizing antibodies
Li, L., Zhao, Z., Yang, X., Li, W., Chen, S., Sun, T., Wang, L., He, Y., Liu, G., Han, X., Wen, H., Liu, Y., Chen, Y., Wang, H., Li, J., Su, Z., Chen, D., Wang, Y., Li, X., Yang, Z., Wang, J., Li, M., Wang, T., Wang, Y., Fan, Y., Wang, H., Zhang, J.
10.1101/2020.12.13.422550 — Posted: 2020-12-13
SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome
Zhang, L., Richards, A., Khalil, A., Wogram, E., Ma, H., Young, R. A., Jaenisch, R.
10.1101/2020.12.12.422516 — Posted: 2020-12-13 Discussion: Onsite | Offsite
A novel cell culture system modeling the SARS-CoV-2 life cycle
Ju, X., Zhu, Y., Wang, Y., Li, J., Zhang, J., Gong, M., Ren, W., Li, S., Zhong, J., Zhang, Q. C., Zhang, R., Ding, Q.
10.1101/2020.12.13.422469 — Posted: 2020-12-13
Evaluation of in vitro activity of copper gluconate against SARS-CoV-2 using confocal microscopy-based high content screening
Rodriguez, K., Rigaill, J., Audoux, E., Saunier, F., Botelho-Nevers, E., Prier, A., Dickerscheit, Y., Pillet, S., Pozzetto, B., Bourlet, T., Verhoeven, P. O.
10.1101/2020.12.13.422548 — Posted: 2020-12-13
Generation of a SARS-CoV-2 Replicon as a Model System to Dissect Virus Replication and Antiviral Inhibition
He, X., Quan, S., Xu, M., Rodriguez, S., Goh, S. L., Wei, J., Fridman, A., Koeplinger, K. A., Carroll, S. S., Grobler, J. A., Espeseth, A. S., Olsen, D. B., Hazuda, D. J., Wang, D.
10.1101/2020.12.12.422532 — Posted: 2020-12-13
The Potential for SARS-CoV-2 to Evade Both Natural and Vaccine-induced Immunity
Shang, E., Axelsen, P.
10.1101/2020.12.13.422567 — Posted: 2020-12-13
Social and racial inequalities in COVID-19 risk of hospitalisation and death across Sao Paulo state, Brazil
Li, S. L., Pereira, R. H. M., Prete, C. A., Zarebski, A. E., Emanuel, L., Alves, P. J. H., Peixoto, P. S., Braga, C. K. V., de Souza Santos, A. A., Souza, W. M., Barbosa, R. J., Buss, L., Mendrone-Junior, A., de Almeida-Neto, C., Ferreira, S. C., Salles, N. A., Marcilio, I., Wu, C.-H., Gouveia, N., Nascimento, V. H., Sabino, E. C., Faria, N. R., Messina, J. P.
10.1101/2020.12.09.20246207 — Posted: 2020-12-12
Millisecond-scale molecular dynamics simulation of spike RBD structure reveals evolutionary adaption of SARS-CoV-2 to stably bind ACE2
Nelson, G., Buzko, O., Bassett, A., Spilman, P. R., Niazi, K., Rabizadeh, S., Soon-Shiong, P.
10.1101/2020.12.11.422055 — Posted: 2020-12-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).